or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Plaza Medical Group, Pc
    Oklahoma Heart Hospital Physicians
    Cor Clinical Research, Llc
    Eminence Research, Llc
    South Oklahoma Heart Research
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Cancer Specialists of Oklahoma
    Oklahoma City, Oklahoma 73112
    Prostate Cancer
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    South Oklahoma Heart Research
    Oklahoma City, Oklahoma 73135
    Venous Thrombosis, Pulmonary Embolism
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Diarrhea Predominant Irritable Bowel Syndrome in Females
    Sooner Clinical Research

    Trial Locations
    Sooner Clinical Research
    Oklahoma Foundation for Digestive Research
    Irritable Bowel Syndrome
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
    Oklahoma University Health Science Center
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Peritoneal Neoplasms
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    MS Center of Oklahoma
    Oklahoma City, Oklahoma
    Multiple Sclerosis, Relapsing-Remitting
    Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
    Health Research Of Oklahoma
    Oklahoma City, Oklahoma 73103
    Psoriatic Arthritis
    Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    MS Center of Oklahoma, Mercy Health Center
    Oklahoma City, Oklahoma
    Multiple Sclerosis, Relapsing-Remitting
    Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Advanced Non-Small Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Pancreatic Cancer
    Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Hematological Neoplasms, Hematopoietic Stem Cell Transplantation
    Protection From Cisplatin Ototoxicity by Lactated Ringers
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Hearing Loss
    High Dose Chemo With Autologous BMT for Treatment of Metastatic Breast Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Breast Neoplasms
    A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Mucositis, Head and Neck Cancer
    Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Metastatic Breast Cancer
    Comparing Over-the-counter Dry Mouth Remedies After Radiation
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Xerostomia
    Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Severe Sepsis
    Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
    Site Reference ID/Investigator# 75279
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Primary Peritoneal Cancer
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    University of Oklahoma Health Science Center
    Oklahoma City, Oklahoma 73104
    Non-Small Cell Lung Cancer
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    ChemoFx® PRO - A Post-Market Data Collection Study
    Oklahoma Gynecologic Oncology Group
    Oklahoma City, Oklahoma 73112
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Pharmacokinetics of Daunorubicin in Treating Young Patients With Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Unspecified Childhood Solid Tumor, Protocol Specific
    A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
    Cancer Care Associates-Oklahoma City
    Oklahoma City, Oklahoma 73112
    Extensive-stage Small Cell Lung Cancer
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    The University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Myelodysplastic Syndrome (MDS)
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    The University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Non-small Cell Lung Cancer
    Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects
    GSK Investigational Site
    Oklahoma City, Oklahoma 73112
    Neoplasms, Breast
    Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
    Oklahoma Oncology and Hematology, PC
    Oklahoma City, Oklahoma 73112
    Relapsed Follicular Lymphoma
    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Sarcoma
    Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
    Investigational Site Number
    Oklahoma City, Oklahoma 73104
    Cancer, Non-Small Cell Lung Cancer, Endometrial Carcinoma, Ovarian Carcinoma
    Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brain Tumor
    Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Non-Hodgkin's Lymphoma
    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma 73104
    Rheumatoid Arthritis
    Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) (The STAR Study)
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Integris Baptist Medical Center
    Thrombotic Thrombocytopenic Purpura
    Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Chemotherapeutic Agent Toxicity, Endometrial Cancer, Fallopian Tube Cancer, Gastrointestinal Complications, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Transfusional Hemosiderosis
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Head and Neck Cancer
    Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia
    Urokinase Like Plasminogen Activator Levels in Patients Undergoing Bronchoscopy
    VA Medical Center
    Oklahoma City, Oklahoma 73104
    Hemoptysis
    A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adnexal Mass, Ovarian Cancer
    Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
    OU Medical Center
    Oklahoma City, Oklahoma 73104
    Breast Cancer
    Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
    Investigational Site Number 1434
    Oklahoma City, Oklahoma 73084
    Endometrial Cancer, Endometrial Neoplasms